These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31545416)

  • 21. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
    Dillard C; Kiyohara M; Mah V; McDermott SP; Bazzoun D; Tsui J; Chan AM; Haddad G; Pellegrini M; Chang YL; Elshimali Y; Wu Y; Vadgama JV; Kim SR; Goodglick L; Law SM; Patel DD; Dhawan P; O'Brien NA; Gordon LK; Braun J; Lazar G; Wicha MS; Wadehra M
    Mol Cancer Ther; 2020 Aug; 19(8):1682-1695. PubMed ID: 32451329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
    Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
    Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
    Cuadros M; Cano C; López FJ; López-Castro R; Concha A
    Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
    Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
    Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer.
    Bai F; Zhang P; Fu Y; Chen H; Zhang M; Huang Q; Li D; Li B; Wu K
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32300050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of LncRNA-GACAT3 with MRI features of breast cancer and its molecular mechanism.
    Hu H; Wang Y; Zhang T; Zhang C; Liu Y; Li G; Zhou D; Lu S
    J BUON; 2019; 24(6):2377-2384. PubMed ID: 31983109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
    Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV
    Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.
    Zhang H; Ren Y; Pang D; Liu C
    World J Surg Oncol; 2014 May; 12():142. PubMed ID: 24884516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
    Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
    Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and prognostic value of L1-CAM in breast cancer.
    Schröder C; Schumacher U; Fogel M; Feuerhake F; Müller V; Wirtz RM; Altevogt P; Krenkel S; Jänicke F; Milde-Langosch K
    Oncol Rep; 2009 Nov; 22(5):1109-17. PubMed ID: 19787228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.